Total cholesterol (343±49 mg/dL vs. 161±12 mg/dL; p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Studies have shown that hypercholesterolemia can induce ventricular vulnerability to fibrillation, and statin therapy exerts antiarrhythmic effects.In the present study, we investigated the relationship between arrhythmogenic substrate and familial hypercholesterolemia(FH) with regard to statin therapy.Methods: We evaluated 46 statin-naive patients (41±12 years) with FH, and 46 healthy subjects (40±8 years) prospectively.Electrocardiography (ECG) of patients were compared before and after 6 months of intensive statin therapy and with controlgroups.
📊
Key Findings & Data:The ECG parameters were calculated by two experienced cardiologists who blinded to each other’s findings.Results: There were no significant differences found between groups’ baseline characteristics.
💡
Conclusion & Impact:Total cholesterol (343±49 mg/dL vs. 161±12 mg/dL; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: Studies have shown that hypercholesterolemia can induce ventricular vulnerability to fibrillation, and statin therapy exerts antiarrhythmic effects.In the present study, we investigated the relationship between arrhythmogenic substrate and familial hypercholesterolemia(FH) with regard to statin therapy.Methods: We evaluated 46 statin-naive patients (41±12 years) with FH, and 46 healthy subjects (40±8 years) prospectively.Electrocardiography (ECG) of patients were compared before and after 6 months of intensive statin therapy and with controlgroups. The ECG parameters were calculated by two experienced cardiologists who blinded to each other’s findings.Results: There were no significant differences found between groups’ baseline characteristics. Total cholesterol (343±49 mg/dL vs. 161±12 mg/dL; p
🔖
Cite This Article
ÇEKİCİ, Y., KILIÇ, S., KÜÇÜKOSMANOĞLU, M., KAYIKCIOĞLU, M., SARAÇOĞLU, E., VURUŞKAN, E. (2022). Effect of Statin Therapyin Tpe-Interval and Tpe/QTc Ratio in Patients with Familial Hypercholesterolemia. European Journal of Therapeutics, Cilt: 26 - Sayı: 3, 165–171. https://ajindex.com/articles/650479
Liu Y-B, Lee Y-T, Pak H-N, Lin S-F, Fishbein MC, Chen LS, et al. Effects of simvastatin on cardiac neural and electrophysiologic remodeling in rabbits with hypercholesterolemia. Heart Rhythm 2009
[Crossref] 2. Tamargo J, Caballero R, Gómez R, Núñez L, Vaquero M, Delpón E. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy. Pharmacol Ther 2007
[Crossref] 3. Buber J, Goldenberg I, Moss AJ, Wang PJ, McNitt S, Hall WJ, et al. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol 2012
[Crossref] 4. Xia Y, Liang Y, Kongstad O, Liao Q, Holm M, Olsson B, et al. In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine. Heart Rhythm 2005
[Crossref] 5. Kongstad O, Xia Y, Liang Y, Hertervig E, Ljungström E, Olsson B, et al. Epicardial and endocardial dispersion of ventricular repolarization. A study of monophasic action potential mapping in healthy pigs. Scand Cardiovasc J 2005
[Crossref] 6. Porthan K, Viitasalo M, Toivonen L, Havulinna AS, Jula A, Tikkanen JT, et al. Predictive value of electrocardiographic T-wave morphology parameters and T-wave peak to T-wave end interval for sudden cardiac death in the general population. Circ Arrhythm Electrophysiol 2013
[Crossref] 7. Laurita KR, Girouard SD, Akar FG, Rosenbaum DS. Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart. Circulation 1998
[Crossref] 8. Antzelevitch C, Viskin S, Shimizu W, Yan G-X, Kowey P, Zhang L, et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 2007
[Crossref] 9. Hovingh GK, Davidson MH, Kastelein JJ, O'connor AM. Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J 2013
[Crossref] 10. Olshausen KV, Witt T, Pop T, Treese N, Bethge K-P, Meyer J. Sudden cardiac death while wearing a Holter monitor. Am J Cardiol 1991
[Crossref] 11. Kuo C-S, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983